Mao Inhibitors + Lorlatinib Interaction
Majorinteraction on record
Description
Avoid concomitant use with strong CYP3A inhibitors; reduce lorlatinib dose if unavoidable. Increases lorlatinib plasma concentrations, increasing adverse reactions.
Mechanism
CYP3A inhibition increases lorlatinib metabolism
Source: NLP:lorlatinib